In 1982 Food and Drug Administration approved Humulin, Eli Lily’s recombinant insulin made from Genentech’s specially modified bacteria. It was the first drug produced through recombinant DNA ...

As luck would have it, new developments in biotechnology provided an alternate source for insulin. Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers ...

Then, in 1986, a publication by the Organization for Economic Cooperation and Development (OECD), called "Recombinant DNA Safety Considerations," became the first intergovernmental document to ...

The development of methods to manipulate DNA opened ... and insulin, both well-studied therapeutics with approved biologic counterparts, were early targeted for recombinant production because ...

Ironically, much further back in history, before the advent of recombinant DNA technology, insulin was extracted from cow pancreases sourced from slaughterhouses. Scientists used a modified virus ...

The first crystal structure of an alternative DNA shape from the insulin gene has been revealed by a UCL-led research team.

This line of study has led to hardier and healthier food crops, the mass production of insulin, and novel vaccines, and it’s all possible because of the work done by biochemist Paul Berg, who became ...

No risk of transferring infections. More effective at treating diabetes as animal insulin is different to human insulin. No ethical issues concerning the use of animals.